Endocrinology Research and Practice
Original Article

Glycemic Control of Turkish Adult Diabetic Patients

1.

Göztepe Training and Research Hospital, Second Internal Medicine Division, İstanbul, Turkey

2.

Hacettepe University, Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, Turkey

3.

Istanbul University, Cerrahpasa Faculty of Medicine, Department of Endocrinology and Metabolism, İstanbul, Turkey

4.

Istanbul University, Faculty of Medicine, Department of Endocrinology and Metabolism, İstanbul, Turkey

5.

Uludağ University, Faculty of Medicine, Department of Endocrinology and Metabolism, Bursa, Turkey

6.

Ankara University, Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, Turkey

7.

Ege University, Faculty of Medicine, Department of Endocrinology and Metabolism, İzmir, Turkey

Endocrinol Res Pract 2008; 12: 50-54
Read: 2313 Downloads: 641 Published: 01 June 2008

Abstract
Objective
: We conducted a cross-sectional observational study to determine the level of glycemic control and other characteristics in adult Turkish patients with diabetes mellitus, who were already receiving treatment.
Materials and Methods: A total of 2358 adult diabetic patients that had been on treatment for at least 3 months and followed in 44 different centers spread throughout Turkey were recruited in the study. Glycemic control was determined by glycosylated hemoglobin (HbA1c) levels using the “A1cNow®” test kit (Metrika Inc. USA) to obtain standard measurements in all centers.
Results: The majority of patients had type 2 diabetes (93.9%). The mean age was 55.7±12.1 years. Patients had been diagnosed with diabetes for 9.1±7.2 years, and they were on treatment for 6.9±6.3 years. In total, 69% of the patients had HbA1c ≥7%, and the mean HbA1c level was 8.0±2.0%. There was no significant difference between male and female patients regarding glycemic control. Of all the patients, 42.7% were obese and 39.7% were overweight. Dyslipidemia and hypertension were present in 76.9% and 88.3% of the patients, respectively.
Conclusions: Diabetes control is insufficient in Turkish patients, and improvements in the current diabetes care standards are needed. 

Türkiye’de Tedavi Altındaki Diyabet Hastalarında Glisemik Kontrol

Özet
Amaç: Türkiye’de tedavi altındaki erişkin diyabetlilerde glisemik kontrol düzeyinin saptanması.
Gereç ve Yöntemler: Kesitsel çalışmaya ülke genelinde 44 merkezden, en azından son 3 aydır tedavi almakta olan diabetes mellituslu 2358 erişkin hasta alındı. Glisemik kontrol tüm merkezlerde standart olarak “A1cNow” (Metrika inc. USA) kitleri kullanılarak belirlenen serum HbA1c düzeylerine gore tanımlandı.
Bulgular: Hastaların büyük çoğunluğu (%93.9) tip 2 diyabetli idi. Ortalama yaş 55.7±12.1 yıl idi. Tanıdan itibaren geçen ortalama süre 9.1±7.2 yıl, tedavi altında oldukları süre 6.9±6.3 yıl idi. Hastaların %64’ünün HbA1c’si %7’nin üzerinde, genel olarak HbA1c düzeyi ortalaması %8±2.0 idi. Kadın ve erkek hastaların glisemik kontrolleri arasında fark yoktu. Hastaların %42.7’si obez, %39.7’si fazla kilolu idi. Dislipidemi ve hipertansiyon sıklıkları sırasıyla %76.9 ve %88.3 idi.
Sonuç: Hastalarımızda diyabet kontrolü yetersizdir. Mevcut diyabet bakım standartlarının düzeltilmesi gereklidir. 
Anahtar kelimeler: Diabetes mellitus, glisemik control, tedavi, HbA1c

 

Files
EISSN 2822-6135